IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. reported strong financial performance for fiscal year 2025, with total revenue of $4.30 billion and net income of $1.06 billion. The company generated a gross profit of $2.66 billion from total cost of revenue of $1.64 billion, resulting in income from operations of $1.36 billion. Operating expenses totaled $1.30 billion, comprising sales and marketing ($643.5 million), general and administrative ($404.8 million), and research and development ($251.2 million). The company maintained solid cash flow from operations of $1.18 billion, though net cash decreased by $108.2 million due to significant stock repurchases of $1.22 billion and investing activities of $136.2 million. The balance sheet shows total assets of $3.35 billion, with current assets of $1.41 billion and stockholders' equity of $1.61 billion. Earnings per share were $13.00 for both basic and diluted calculations.

Key Takeaways